About us Contacts Interactions: 118 620
Drug search by name

Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous and Thromboembolism

Result of checking the interaction of drug Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous and disease Thromboembolism for safety when used together.

Check result:
Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous <> Thromboembolism
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Thromboembolic events, including venous thrombophlebitis, pulmonary embolism, pulmonary infarction, cerebrovascular occlusion (stroke), and arterial occlusion resulting in loss of limb, have been reported during administration of gonadotropin therapy, both in association with and independent of the Ovarian Hyperstimulation Syndrome. Therapy with gonadotropins should be administered cautiously to patients with or predisposed to thromboembolism.

References:
  • "Product Information. Humegon (menotropins)." Organon, West Orange, NJ.
Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous

Generic Name: menotropins

Brand Name: Menopur, Repronex, Pergonal, Humegon

Synonyms: Menotropins

What is Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous?
Another drug Delete
The list of popular interactions
DiseDoc World
Interaction with food and lifestyle
  1. Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous
Drug interactions
  1. Follicle stimulating hormone and luteinizing hormone Intramuscular, Subcutaneous
We use cookies to improve the site's performance. By continuing, you agree to use the cookies. OK